London Daily

Focus on the big picture.
Saturday, Oct 03, 2026

China Vaccine Doses Pass 1 Billion Mark: Officials

China Vaccine Doses Pass 1 Billion Mark: Officials

China's Sinovac previously said trials of its shot in Brazil showed around 50 percent efficacy in preventing infection and 80 percent in preventing cases requiring medical intervention.

The number of Covid-19 jabs administered in China has passed the one billion mark, health officials said Sunday, more than a third of the doses given worldwide.

The announcement by the National Health Commission comes after the number of shots administered globally surpassed 2.5 billion on Friday, according to an AFP count from official sources.

It is unclear what percentage of China's population has now been inoculated but its vaccination drive got off to a slow start after a successful fight against the virus left little sense of urgency to get jabbed.

A lack of transparency and previous vaccine scandals have also led to resistance among residents.

Authorities have set an ambitious target of fully vaccinating 40 percent of the country's nearly 1.4 billion people by the end of this month.

Some provinces are offering vaccines for free to encourage people to roll up their sleeves. Residents in central Anhui province have been given free eggs, while some living in Beijing have received shopping coupons.

A recent outbreak of the more contagious Delta variant of the virus in the southern city of Guangzhou has also served as a wake-up call for many dragging their feet.

China reported 23 new coronavirus cases Sunday.

The country has four conditionally approved vaccines, whose published efficacy rates remain behind rival jabs by Pfizer-BioNTech and Moderna, which have 95 percent and 94 percent success rates respectively.

China's Sinovac previously said trials of its shot in Brazil showed around 50 percent efficacy in preventing infection and 80 percent in preventing cases requiring medical intervention.

Sinopharm's two vaccines have efficacy rates of 79 percent and 72 percent respectively, while the overall efficacy for CanSino's stands at 65 percent after 28 days.

Many of them require two doses.

China is expected to produce more than three billion vaccine doses this year, state news agency Xinhua reported in April.

Health authorities have not said when China will reach herd immunity or what proportion of its vaccine doses will be sold abroad.

Comments

Oh ya 5 year ago
Ya sheeple take a jab from the people that developed the problem. Sounds fair if your 1 working brain cell died

Newsletter

Related Articles

0:00
0:00
Close
Church of England to Apologize for Role in Historical Forced Adoptions
UK Defence Ministry Investigates Historical Use of RAF Bases by Jeffrey Epstein
Scottish Housing Completions Fall to 11-Year Low
Welsh First Minister Calls for Expanded Devolution Settlement
UK Pledges £50 Million to Expand Domestic Military Drone Capabilities
UK Opens First Commercial Geothermal Plant in Cornwall
Green Party Wins Gorton and Denton By-Election as Labour Falls to Third
Prime Minister Andy Burnham Opens Review of UK-EU Relationship
UK Inflation Rises to 3.1%, Adding Pressure on Household Finances
UK Removes VAT From Domestic Electricity Bills to Ease Winter Energy Costs
Counterterrorism Police Arrest Sixth Suspect Over RAF Fairford Incident
UK Councils to Receive Sweeping Planning Powers to Ban New Vape and Betting Shops
Chancellor John Healey Faces Tax and Pension Scrutiny Ahead of Autumn Budget
Metropolitan Police Apologise for Accidental Disclosure in High-Profile Investigation
UK Universities Report Record International Enrolment as Housing Pressure Grows
UK Logistics Firms Monitor Rhine Disruption as Low Water Threatens European Supply Chains
UK Food Industry Warns Inflation Could Approach 7%
UK Introduces Vaping Duty and Mandatory Retail Stamps
Scotland Raises Property Taxes and Expands Child Payment in Annual Budget
Greggs Plans Four Factory Closures With 740 Jobs at Risk
OECD Raises UK 2026 Growth Forecast to 1.1%
UK Inflation Rises to 3.1% as Bank of England Faces Rate Debate
Andy Burnham Criticises Brexit and Says Rejoining EU Single Market Remains an Option
UK Imposes New Sanctions on Russian Military Networks and Propagandists
UK Launches Nationwide Early-Release Prison Scheme
Andy Burnham Says Security Services See Signs of Iranian Involvement in RAF Fairford Incident
Manchester City Found Guilty on Premier League Financial Charges After Independent Investigation
Scottish Court to Rule on Bid to Force No-Confidence Vote Against Aberdeen Council Co-Leader
UK Bans Extra Charges for Seating Children Under 12 Beside Accompanying Adults
UK Introduces Vaping Duty and New Licensing Requirements
Greggs to Close Four UK Factories and Cut 740 Jobs
Hundreds of Prisoners Released Early as England and Wales Prisons Reach 98% Capacity
UK Unveils New Russia Sanctions Targeting War Funding and Shadow Fleet
Burnham Says There Are Strong Indications of Iranian Involvement in RAF Fairford Security Breach
Prime Minister Andy Burnham Raises Prospect of Reviewing Britain's Post-Brexit EU Relationship
Markets Price in Bank of England Rate Increases as Inflation Rises to 3.1%
UK Borrowing Costs Climb Toward 5.5% as Global Bond Sell-Off Intensifies
UK-France One-In-One-Out Migration Agreement Expires as London Seeks Alternative Measures
Southwest England Faces Flood Alerts After Heavy Autumn Storms
UK Expands Funding for Rapid Electric Vehicle Charging Infrastructure
Welsh Government Approves Funding to Upgrade South Wales Transport
Northern Ireland Tensions Rise as Orange Order Rejects Drumcree Compromise
NHS Leaders Back Early Design of Proposed National Care Service
More Than One-Third of Regional UK Universities Face Financial Deficits
UK Current Account Deficit Narrows as Cross-Border Financial Flows Remain Strong
Bank of England and FCA Issue New Rules for Stablecoins and Digital Assets
MI5 Warns UK Universities Over Research Links With Chinese Institutions
UK Energy Price Cap Rises 4% as Electricity VAT Is Temporarily Suspended
Equity Calls for UK Personality Rights to Protect Performers From AI Replication
OpenAI Pauses Advanced Model Training Following Safety Concerns
×